KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Rad Laboratories (BIO) Interest Expenses (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Interest Expenses for 17 consecutive years, with $12.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Interest Expenses fell 0.7% to $12.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $49.0 million, a 0.24% change, with the full-year FY2025 number at $49.0 million, changed 0.2% from a year prior.
  • Interest Expenses was $12.1 million for Q4 2025 at Bio-Rad Laboratories, down from $12.3 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $12.6 million in Q2 2025 to a low of $363000.0 in Q2 2021.
  • A 5-year average of $9.3 million and a median of $12.1 million in 2024 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: plummeted 93.68% in 2021, then soared 3105.77% in 2022.
  • Bio-Rad Laboratories' Interest Expenses stood at $364000.0 in 2021, then skyrocketed by 3105.77% to $11.7 million in 2022, then increased by 5.6% to $12.3 million in 2023, then dropped by 1.11% to $12.2 million in 2024, then dropped by 0.7% to $12.1 million in 2025.
  • Per Business Quant, the three most recent readings for BIO's Interest Expenses are $12.1 million (Q4 2025), $12.3 million (Q3 2025), and $12.6 million (Q2 2025).